Cargando…

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report

PURPOSE: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a necrotizing vasculitis syndrome characterized by the destruction of small vessels, leading to various organ disorders. Here, we report a case of posterior scleritis with AAV successfully treated with prednisolone a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Xinyu, Iwata, Daiju, Namba, Kenichi, Suzuki, Kayo, Mizuuchi, Kazuomi, Nakamura, Hiroyuki, Atsumi, Tatsuya, Ishida, Susumu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802867/ https://www.ncbi.nlm.nih.gov/pubmed/35128165 http://dx.doi.org/10.1016/j.ajoc.2022.101333

Ejemplares similares

A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination
por: Ogino, Yo, et al.
Publicado: (2023)

Two cases of cytomegalovirus panuveitis in immunocompetent patients
por: Sakai, Masato, et al.
Publicado: (2018)

A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet
por: Suzuki, Kayo, et al.
Publicado: (2022)

Diagnostic Accuracy of Cell Block Preparations and Clinical Features Affecting It in Vitreoretinal Lymphoma
por: Kase, Satoru, et al.
Publicado: (2022)

A case of tubulointerstitial nephritis and uveitis syndrome accompanied by subclinical choroiditis
por: Arita, Takuya, et al.
Publicado: (2023)

Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids
por: Hirooka, Kiriko, et al.
Publicado: (2015)

Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids
por: Hirooka, Kiriko, et al.
Publicado: (2017)

Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis
por: Uraki, Takehiko, et al.
Publicado: (2019)

Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma
por: Suzuki, Kayo, et al.
Publicado: (2022)

Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging
por: Fukutsu, Kanae, et al.
Publicado: (2020)

Fundus autofluorescence imaging in acute posterior multifocal placoid pigment epitheliopathy
por: Yokoi, Koichi, et al.
Publicado: (2022)

Diagnostic efficacy of cell block method for vitreoretinal lymphoma
por: Kase, Satoru, et al.
Publicado: (2016)

Multiple evanescent white dot syndrome and panuveitis: a case report
por: Mizuuchi, Kazuomi, et al.
Publicado: (2020)

A Case of Severe Panuveitis Associated with Psoriasis Vulgaris Successfully Treated with Infliximab
por: Sakurai, Yuri, et al.
Publicado: (2016)

Optic Nerve Head Microcirculation in Eyes with Vogt-Koyanagi-Harada Disease Accompanied by Anterior Ischemic Optic Neuropathy
por: Yamashita, Yui, et al.
Publicado: (2021)

Commentary: Rituximab in scleritis
por: Dutta Majumder, Parthopratim
Publicado: (2020)

Combined Infliximab and Rituximab in Necrotising Scleritis
por: Morarji, Jiten, et al.
Publicado: (2012)

Rituximab for non-infectious Uveitis and Scleritis
por: Ng, Caleb C., et al.
Publicado: (2021)

ANCA‐associated vasculitis with scleritis, corneal melt, and perforation rescued by rituximab: Case report and literature review
por: Matsuo, Toshihiko, et al.
Publicado: (2023)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017)

Bacterial endophthalmitis caused by an intraocular cilium in a patient under treatment with infliximab
por: Jin, Xue-hai, et al.
Publicado: (2013)

Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis
por: Suzuki, Kayo, et al.
Publicado: (2023)

Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial
por: Gopaluni, Seerapani, et al.
Publicado: (2017)

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020)

Efficacy and maintenance of rituximab treatment in non‐infectious scleritis
por: Vergouwen, Daphne P. C., et al.
Publicado: (2021)

Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Shah, Shivani, et al.
Publicado: (2017)

A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
por: Awad, Neveen, et al.
Publicado: (2016)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
por: Moog, Philipp, et al.
Publicado: (2015)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission
por: Muto, Reiko, et al.
Publicado: (2020)

Case series: rituximab in the treatment of refractory sight-threatening scleritis
por: van Bilsen, Kiki, et al.
Publicado: (2011)

Intravitreal Injection of Bevacizumab in a Case of Occlusive Retinal Vasculitis Accompanied by Syphilitic Intraocular Inflammation
por: Ishijima, Kan, et al.
Publicado: (2012)

Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
por: Yoneva, Tsvetelina, et al.
Publicado: (2022)

P20 Scleritis as initial presenting feature in ANCA-associated vasculitis
por: Peddasomayajula, Subrahmanyam, et al.
Publicado: (2021)

Scleritis and sclerokeratitis associated with IgA vasculitis: A case series
por: Hernanz, I., et al.
Publicado: (2021)

Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Hogan, Susan L., et al.
Publicado: (2019)

Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats
por: Lennikov, Anton, et al.
Publicado: (2014)

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
por: Latimer, Nicholas R., et al.
Publicado: (2014)

Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
por: Kant, Sam, et al.
Publicado: (2022)

A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Watanabe-Kusunoki, Kanako, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ui88qbr2re8danj8pki880hcs